Are you a former employee of Glaukos Corporation (GKOS) or Avedro, Inc. (AVDR) and own stock in the company? Robbins LLP is investigating breaches of fiduciary duty by the officers and board of directors of GKOS.

Glaukos Corporation (GKOS) Completes Acquisition of Avedro, Inc. (AVDR) for $500 million

In August 2019, Glaukos agreed to acquire cross-linking company Avedro in an all-stock transaction. Under the terms of the deal, Glaukos paid about $26.68 per share for a total value of about $500 million and completed the acquisition in November 2019. The companies touted the synergistic avenues for potential long-term growth between the two companies, with Avedro's former CEO stating that the Company "is extremely pleased with the potential to become part of Glaukos" and that he believed the "transaction would benefit customers, employees and patients, while creating value for shareholders through ownership in a combined company with the expertise, scale, and resources to drive meaningful future growth." Despite these auspicious statements, on February 27, 2020, Glaukos revealed an 86% increase in selling, general and administrative expenses, and a 55% increase in its research and development expenses as well as a loss from operations of $29.7 million in its fourth quarter 2019 results. On this news, Glaukos' stock price fell 28% to close at $43.98 per share. The stock continues to decline.